As of November 6, 2026, Staar Surgical Co. is a publicly traded company (Nasdaq: STAA). The largest holder reporting an active stake on Schedule 13D is Broadwood Partners, L.P., at 32.6%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include BlackRock (9.2%), Madison Avenue International LP (8.4%), Point72 (5.2%) (Schedule 13D/A, March 13, 2026).
Is this your company?
About to sign with, pay or invest in Staar Surgical Co.? See the free Snapshot first.
Free to see. No signup.
Is Staar Surgical Co. a real, registered company?
- Staar Surgical Co files with the SEC under CIK 718937 (its SEC filings).
- Its shares are listed under the ticker STAA on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Monrovia, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under STAAR SURGICAL CO in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Warren Foust, President and Chief Executive Officer (Form 8-K filed 2026-08-06). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-10-27).
Who are Staar Surgical Co.'s owners and officers?
Staar Surgical Co.: incorporated in Delaware; business address in Monrovia, California; industry Ophthalmic Goods (Schedule 13G/A, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-27 | Blackrock, Inc. | 9.2% |
| Schedule 13G/A, 2026-08-14 | Madison Avenue International LP | 8.4% |
| Schedule 13G, 2026-05-12 | Point72 Asset Management, L.P. | 5.2% |
| Schedule 13G/A, 2026-04-24 | Blackrock, Inc. | 13.1% |
| Schedule 13G, 2026-04-20 | Madison Avenue International LP | 5.8% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13D/A, 2026-03-13 | Broadwood Partners, L.P. | 32.6% |
| Schedule 13D/A, 2026-01-16 | Broadwood Partners, L.P. | 31.1% |
| Schedule 13D/A, 2026-01-16 | Yunqi Capital Limited | 6.5% |
| Schedule 13D/A, 2026-01-08 | Yunqi Capital Limited | 6.5% |
| Schedule 13D/A, 2025-12-17 | Broadwood Partners, L.P. | 30.2% |
| Schedule 13D/A, 2025-12-11 | Yunqi Capital Limited | 5.1% |
Questions about who owns Staar Surgical Co.
Who owns Staar Surgical Co.?
On this page, 5 holders' latest ownership filings report 5% or more of Staar Surgical Co.: Broadwood Partners, L.P. (32.6%, Schedule 13D/A, filed 2026-03-13), Blackrock, Inc. (9.2%, Schedule 13G/A, filed 2026-10-27), Madison Avenue International LP (8.4%, Schedule 13G/A, filed 2026-08-14), Yunqi Capital Limited (6.5%, Schedule 13D/A, filed 2026-01-16) and Point72 Asset Management, L.P. (5.2%, Schedule 13G, filed 2026-05-12).
Who are the largest shareholders of Staar Surgical Co.?
By the share each holder's latest filing reports, the largest holders of Staar Surgical Co. on this page are Broadwood Partners, L.P. (32.6%), Blackrock, Inc. (9.2%) and Madison Avenue International LP (8.4%).
When did Broadwood Partners, L.P. buy into Staar Surgical Co.?
The filings give report dates, not purchase dates. The earliest filing from Broadwood Partners, L.P. on this page is the Schedule 13D/A, filed 2025-12-17, reporting 30.2%; its latest, Schedule 13D/A filed 2026-03-13, reports 32.6%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Staar Surgical Co.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Staar Surgical Co.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Staar Surgical Co. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-06 | Warren Foust | President and Chief Executive Officer | appointed | 2026-08-04 |
Which insiders own Staar Surgical Co. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Broadwood Capital Inc., a 10% owner: 63,563,902 shares, 31,931,667 held directly and 31,632,235 indirectly, on a joint filing (Form 4, 2026-03-13).
- , a director and 10% owner: 63,563,902 shares, 31,931,667 held directly and 31,632,235 indirectly, on a joint filing (Form 4, 2026-03-13).
- Broadwood Partners, L.P., a director and 10% owner: 63,563,902 shares, 31,931,667 held directly and 31,632,235 indirectly, on a joint filing (Form 4, 2026-03-13).
- , a director: 3,257,130 shares (6.5% of shares outstanding), held indirectly (the form names the holder only in its footnotes) (Form 3, 2026-02-10).
- , the chief executive and president: 95,816 shares (0.19% of shares outstanding) (Form 4, 2026-08-18).
Shares outstanding: 50,201,819 as of 2026-10-30, from the company's latest SEC cover page.
How much has Staar Surgical Co. raised?
No fundraising or offering filing from Staar Surgical Co. is on file with us.
Keep reading
More on Staar Surgical Co. and the records around it.
Staar Surgical Co. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Sep 2026
Companies that share a holder
- Broadwood Partners, L.P. also filed stake reports on 2 other companies: Insight Molecular Diagnostics Inc. (Apr 2026), Lineage Cell Therapeutics, Inc. (Nov 2025)
- Madison Avenue International LP also filed stake reports on 11 other companies: Ultragenyx Pharmaceutical Inc. (Oct 2026), Graham Holdings Co (Aug 2026), Theravance Biopharma, Inc. (Aug 2026)
- Soleus Capital Master Fund, L.P. also filed stake reports on 24 other companies: Beta Bionics, Inc. (Nov 2026), Evolus, Inc (Nov 2026), INSPIRE MEDICAL SYSTEMS, INC. (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/staar-surgical